Dementia,1005489.0,9164.0
Tremor,1005489.0,673.0
Therapeutic product effect incomplete,1005489.0,4705.0
Product use in unapproved indication,1005489.0,14785.0
Hypogammaglobulinaemia,1005489.0,246.0
Toxicity to various agents,1005489.0,9815.0
Night sweats,1005489.0,1814.0
Deafness,1005489.0,1233.0
Galactorrhoea,1005489.0,50.0
Lower respiratory tract infection,1005489.0,4859.0
Live birth,1005489.0,1716.0
Drug interaction,1005489.0,9570.0
Joint range of motion decreased,1005489.0,2108.0
Hypoacusis,1005489.0,155.0
Treatment failure,1005489.0,6287.0
Vitamin B12 decreased,1005489.0,183.0
Tooth disorder,1005489.0,827.0
Ulcer haemorrhage,1005489.0,1716.0
Lip dry,1005489.0,3529.0
Skin plaque,1005489.0,78.0
Injection site reaction,1005489.0,1149.0
Musculoskeletal stiffness,1005489.0,6343.0
Grip strength decreased,1005489.0,3291.0
Fluid retention,1005489.0,645.0
Wound,1005489.0,5839.0
Nausea,1005489.0,6560.0
Anuria,1005489.0,169.0
Maternal exposure during pregnancy,1005489.0,4915.0
Fall,1005489.0,13231.0
Hypoaesthesia,1005489.0,2185.0
Haemolysis,1005489.0,176.0
Acute kidney injury,1005489.0,148.0
Magnetic resonance imaging head abnormal,1005489.0,64.0
Synovitis,1005489.0,7610.0
Sinusitis,1005489.0,3886.0
Ear pain,1005489.0,1989.0
Abdominal pain upper,1005489.0,3088.0
Respiratory disorder,1005489.0,1716.0
Facet joint syndrome,1005489.0,1716.0
Product label confusion,1005489.0,1611.0
Pulmonary fibrosis,1005489.0,2948.0
Headache,1005489.0,7127.0
Bone pain,1005489.0,246.0
Gait disturbance,1005489.0,3354.0
Total lung capacity decreased,1005489.0,141.0
Dehydration,1005489.0,316.0
Adverse event,1005489.0,2948.0
Irritability,1005489.0,267.0
Rash,1005489.0,5958.0
Congenital aplasia,1005489.0,1016.0
Dry mouth,1005489.0,3788.0
Off label use,1005489.0,22170.0
Neutropenia,1005489.0,197.0
Pericarditis,1005489.0,4782.0
Vomiting,1005489.0,7715.0
Product quality issue,1005489.0,3375.0
Hypotension,1005489.0,10431.0
Stupor,1005489.0,29.0
Frustration tolerance decreased,1005489.0,183.0
Systemic lupus erythematosus,1005489.0,4719.0
Product dispensing error,1005489.0,1023.0
Obesity,1005489.0,1814.0
Impaired healing,1005489.0,1814.0
Anxiety,1005489.0,2500.0
Drug intolerance,1005489.0,6231.0
Loss of personal independence in daily activities,1005489.0,2563.0
Drug tolerance,1005489.0,1716.0
Agitation,1005489.0,99.0
Memory impairment,1005489.0,1926.0
Hepatic enzyme increased,1005489.0,5930.0
General physical health deterioration,1005489.0,3130.0
Cough,1005489.0,4432.0
Wheezing,1005489.0,4390.0
Peripheral swelling,1005489.0,6441.0
Overdose,1005489.0,9472.0
Glossodynia,1005489.0,3424.0
Hepatitis,1005489.0,2955.0
Platelet count decreased,1005489.0,631.0
Mobility decreased,1005489.0,10886.0
Contraindicated product administered,1005489.0,5804.0
Illness,1005489.0,1282.0
Therapeutic product effect decreased,1005489.0,8205.0
Abdominal pain,1005489.0,3340.0
Hypoxia,1005489.0,1058.0
Pyrexia,1005489.0,4467.0
Cerebrovascular accident,1005489.0,1555.0
Coeliac disease,1005489.0,2759.0
Intentional product use issue,1005489.0,3459.0
Diarrhoea,1005489.0,3564.0
Lung disorder,1005489.0,3886.0
Blood calcium decreased,1005489.0,9164.0
Depressed level of consciousness,1005489.0,9164.0
Therapy non-responder,1005489.0,1863.0
Prescribed overdose,1005489.0,1716.0
Drug abuse,1005489.0,9164.0
Multiple drug therapy,1005489.0,2619.0
Blood pressure decreased,1005489.0,778.0
Brain oedema,1005489.0,106.0
Dizziness,1005489.0,4138.0
Feeling abnormal,1005489.0,841.0
Fibromyalgia,1005489.0,2024.0
Creatinine renal clearance decreased,1005489.0,9164.0
Weight increased,1005489.0,7883.0
Swelling,1005489.0,2969.0
Exercise tolerance decreased,1005489.0,351.0
Infusion related reaction,1005489.0,5552.0
Pemphigus,1005489.0,4677.0
Ectopic pregnancy,1005489.0,71.0
Nasal neoplasm,1005489.0,43.0
Intercepted product dispensing error,1005489.0,43.0
Rheumatoid arthritis,1005489.0,7988.0
Blood cholesterol increased,1005489.0,2759.0
Musculoskeletal pain,1005489.0,1814.0
Osteoarthritis,1005489.0,1114.0
Hemiplegia,1005489.0,1555.0
Stomatitis,1005489.0,3543.0
Red blood cell sedimentation rate increased,1005489.0,4271.0
Cerebral artery thrombosis,1005489.0,1555.0
Oedema peripheral,1005489.0,2269.0
Eye pruritus,1005489.0,183.0
Condition aggravated,1005489.0,7512.0
Joint swelling,1005489.0,11754.0
Angina pectoris,1005489.0,351.0
Insomnia,1005489.0,7295.0
Anti-cyclic citrullinated peptide antibody positive,1005489.0,5139.0
Burning sensation,1005489.0,253.0
Hand deformity,1005489.0,3501.0
Pain,1005489.0,15695.0
Vaccination failure,1005489.0,113.0
Weight decreased,1005489.0,6567.0
Areflexia,1005489.0,1555.0
Ulcer,1005489.0,1716.0
Hypertension,1005489.0,4453.0
Pruritus,1005489.0,3655.0
Cervical radiculopathy,1005489.0,253.0
Drug hypersensitivity,1005489.0,4859.0
Migraine,1005489.0,1989.0
Panniculitis,1005489.0,1233.0
Hypersensitivity,1005489.0,7596.0
Blood glucose abnormal,1005489.0,295.0
Muscle injury,1005489.0,3529.0
Joint stiffness,1005489.0,1716.0
Respiratory failure,1005489.0,1667.0
Back pain,1005489.0,610.0
Gastrointestinal disorder,1005489.0,4614.0
Hypercalcaemia,1005489.0,1233.0
Sedation,1005489.0,9318.0
Carcinoid crisis,1005489.0,134.0
Alanine aminotransferase increased,1005489.0,1233.0
Haematuria,1005489.0,211.0
Taste disorder,1005489.0,3326.0
Graves' disease,1005489.0,211.0
Rheumatoid factor positive,1005489.0,2948.0
Epilepsy,1005489.0,1716.0
Drug eruption,1005489.0,1324.0
Exposure during pregnancy,1005489.0,3942.0
Dyspepsia,1005489.0,3690.0
Productive cough,1005489.0,1149.0
Lower limb fracture,1005489.0,3781.0
Arthralgia,1005489.0,9283.0
Obstructive airways disorder,1005489.0,1065.0
Drug ineffective,1005489.0,7897.0
Rash pruritic,1005489.0,1233.0
Peripheral venous disease,1005489.0,1716.0
Kidney infection,1005489.0,92.0
Injury,1005489.0,1744.0
Arthritis,1005489.0,1562.0
Intestinal ulcer,1005489.0,533.0
Blood pressure increased,1005489.0,1765.0
Lyme disease,1005489.0,106.0
Angiopathy,1005489.0,113.0
Laryngitis,1005489.0,1716.0
Body temperature decreased,1005489.0,778.0
Fatigue,1005489.0,11362.0
Liver function test increased,1005489.0,1975.0
Fracture delayed union,1005489.0,92.0
Syncope,1005489.0,99.0
Prescribed underdose,1005489.0,2948.0
Decreased appetite,1005489.0,1156.0
Abdominal discomfort,1005489.0,5055.0
Sleep disorder,1005489.0,2024.0
Foetal exposure during pregnancy,1005489.0,36.0
Adverse drug reaction,1005489.0,2626.0
Hip arthroplasty,1005489.0,1814.0
Dyspnoea,1005489.0,17438.0
Herpes zoster,1005489.0,155.0
Drug-induced liver injury,1005489.0,1611.0
Dyspnoea exertional,1005489.0,1191.0
Tooth injury,1005489.0,85.0
Foot fracture,1005489.0,631.0
Cardiogenic shock,1005489.0,78.0
Skin ulcer,1005489.0,1233.0
C-reactive protein abnormal,1005489.0,92.0
Endometriosis,1005489.0,246.0
Pneumonia,1005489.0,4565.0
Multiple organ dysfunction syndrome,1005489.0,1247.0
Somnolence,1005489.0,729.0
Disease recurrence,1005489.0,2024.0
Temporomandibular pain and dysfunction syndrome,1005489.0,498.0
Nervousness,1005489.0,162.0
Ocular hypertension,1005489.0,253.0
Gait inability,1005489.0,1716.0
Folliculitis,1005489.0,3529.0
Cheilitis,1005489.0,78.0
Paraesthesia,1005489.0,2367.0
Meningococcal sepsis,1005489.0,113.0
Orthostatic hypotension,1005489.0,9493.0
Nasal congestion,1005489.0,1849.0
Alopecia,1005489.0,7687.0
Blood parathyroid hormone decreased,1005489.0,2465.0
Adjustment disorder with depressed mood,1005489.0,1716.0
Adverse reaction,1005489.0,1611.0
Amnesia,1005489.0,1716.0
Muscle spasms,1005489.0,4502.0
Flushing,1005489.0,386.0
Metastases to bone,1005489.0,64.0
Nerve compression,1005489.0,274.0
Maternal exposure before pregnancy,1005489.0,176.0
Pleural effusion,1005489.0,218.0
Chondromalacia,1005489.0,246.0
Medication error,1005489.0,4656.0
Product use issue,1005489.0,9150.0
Localised infection,1005489.0,736.0
Finger deformity,1005489.0,1611.0
Bursitis,1005489.0,2066.0
Nephrolithiasis,1005489.0,330.0
Inflammation,1005489.0,4852.0
Arthropathy,1005489.0,4082.0
Drug tolerance decreased,1005489.0,1233.0
Infusion site reaction,1005489.0,1716.0
Road traffic accident,1005489.0,1331.0
Sensation of foreign body,1005489.0,78.0
Wound infection,1005489.0,1716.0
Exostosis,1005489.0,1716.0
Rheumatoid nodule,1005489.0,1233.0
Perfume sensitivity,1005489.0,99.0
Liver injury,1005489.0,1716.0
Creatinine renal clearance increased,1005489.0,9164.0
Hereditary angioedema,1005489.0,92.0
Cognitive disorder,1005489.0,9206.0
Unevaluable event,1005489.0,911.0
Blister,1005489.0,1891.0
Respiratory distress,1005489.0,1555.0
Skin exfoliation,1005489.0,78.0
Myocardial ischaemia,1005489.0,50.0
Throat irritation,1005489.0,386.0
Dizziness postural,1005489.0,603.0
Coronary artery thrombosis,1005489.0,106.0
Coma,1005489.0,127.0
Haemodynamic instability,1005489.0,1261.0
Hepatitis acute,1005489.0,43.0
Influenza like illness,1005489.0,323.0
Renal function test abnormal,1005489.0,9164.0
Pulmonary congestion,1005489.0,274.0
Spinal stenosis,1005489.0,533.0
Irritable bowel syndrome,1005489.0,1723.0
Muscular weakness,1005489.0,232.0
Trismus,1005489.0,64.0
Onychomycosis,1005489.0,1149.0
Gastritis,1005489.0,106.0
Loss of consciousness,1005489.0,316.0
Eye pain,1005489.0,197.0
Death,1005489.0,1023.0
Hepatic encephalopathy,1005489.0,29.0
Joint warmth,1005489.0,330.0
Sepsis,1005489.0,288.0
Thrombocytopenia,1005489.0,120.0
Lupus-like syndrome,1005489.0,1737.0
Hysterectomy,1005489.0,246.0
Constipation,1005489.0,10438.0
Sciatica,1005489.0,1716.0
Complex regional pain syndrome,1005489.0,253.0
Oedema,1005489.0,1814.0
Superficial spreading melanoma stage unspecified,1005489.0,148.0
Completed suicide,1005489.0,365.0
Human polyomavirus infection,1005489.0,155.0
Splenomegaly,1005489.0,64.0
Swollen joint count increased,1005489.0,2864.0
Depression,1005489.0,624.0
C-reactive protein increased,1005489.0,1233.0
Granuloma skin,1005489.0,1233.0
Breath sounds abnormal,1005489.0,1233.0
Ill-defined disorder,1005489.0,1814.0
Anaemia,1005489.0,190.0
Hallucination,1005489.0,1499.0
Erythema,1005489.0,1471.0
Hyperhidrosis,1005489.0,295.0
Non-Hodgkin's lymphoma,1005489.0,2458.0
Sedation complication,1005489.0,9164.0
Clostridium difficile colitis,1005489.0,1016.0
Abdominal distension,1005489.0,1870.0
Electrocardiogram QT prolonged,1005489.0,134.0
Palmar-plantar erythrodysaesthesia syndrome,1005489.0,78.0
Osteoporosis,1005489.0,533.0
Animal bite,1005489.0,596.0
Asthma,1005489.0,1989.0
Respiratory tract congestion,1005489.0,435.0
Type 2 diabetes mellitus,1005489.0,3641.0
Product administration error,1005489.0,918.0
Skin discolouration,1005489.0,92.0
Hip surgery,1005489.0,106.0
Graft versus host disease,1005489.0,911.0
Rash erythematous,1005489.0,1135.0
Bronchial hyperreactivity,1005489.0,141.0
Malaise,1005489.0,5993.0
Urticaria,1005489.0,2409.0
Confusional state,1005489.0,1947.0
Tuberculin test positive,1005489.0,1548.0
Colorectal adenocarcinoma,1005489.0,85.0
Coronary artery disease,1005489.0,148.0
Tongue disorder,1005489.0,225.0
Myalgia,1005489.0,232.0
Rheumatic fever,1005489.0,2864.0
Blood pressure systolic abnormal,1005489.0,1030.0
Movement disorder,1005489.0,1149.0
Tic,1005489.0,50.0
Basal cell carcinoma,1005489.0,1233.0
Sleep disorder due to a general medical condition,1005489.0,1716.0
Vertigo,1005489.0,407.0
Blindness unilateral,1005489.0,106.0
Forced expiratory volume decreased,1005489.0,988.0
Pharyngitis streptococcal,1005489.0,57.0
Liver function test abnormal,1005489.0,344.0
Nasopharyngitis,1005489.0,5370.0
Insurance issue,1005489.0,113.0
Rash pustular,1005489.0,1016.0
Gingival disorder,1005489.0,22.0
Lung neoplasm malignant,1005489.0,274.0
Pharyngitis,1005489.0,50.0
Gallbladder disorder,1005489.0,386.0
Snoring,1005489.0,155.0
Aspartate aminotransferase increased,1005489.0,1233.0
Intervertebral disc protrusion,1005489.0,134.0
Lower respiratory tract congestion,1005489.0,932.0
Dysentery,1005489.0,22.0
Craniofacial fracture,1005489.0,8.0
Circumstance or information capable of leading to medication error,1005489.0,43.0
Oesophageal stenosis,1005489.0,57.0
Incorrect route of product administration,1005489.0,1716.0
Upper respiratory tract infection,1005489.0,211.0
Thyroid disorder,1005489.0,127.0
Contusion,1005489.0,1191.0
Blood pressure systolic increased,1005489.0,1219.0
Nerve injury,1005489.0,253.0
Muscle tightness,1005489.0,911.0
Necrotising herpetic retinopathy,1005489.0,50.0
Chronic obstructive pulmonary disease,1005489.0,267.0
Tuberculosis,1005489.0,64.0
Back injury,1005489.0,106.0
Bronchitis,1005489.0,995.0
Rhinovirus infection,1005489.0,351.0
Influenza,1005489.0,981.0
Bladder disorder,1005489.0,9941.0
Septic shock,1005489.0,155.0
Eating disorder,1005489.0,99.0
Helicobacter infection,1005489.0,1814.0
Duodenal ulcer perforation,1005489.0,1716.0
Pain in extremity,1005489.0,1457.0
Skin burning sensation,1005489.0,302.0
Cardiac failure congestive,1005489.0,505.0
Focal dyscognitive seizures,1005489.0,155.0
Duodenal ulcer,1005489.0,288.0
Weight fluctuation,1005489.0,939.0
Facial paralysis,1005489.0,1555.0
Catheter site irritation,1005489.0,71.0
Hypophagia,1005489.0,92.0
Hypokinesia,1005489.0,568.0
Quality of life decreased,1005489.0,148.0
Compartment syndrome,1005489.0,8.0
Clostridium difficile infection,1005489.0,274.0
Neck pain,1005489.0,162.0
Purpura,1005489.0,204.0
Blood pressure diastolic decreased,1005489.0,1513.0
Nasal polyps,1005489.0,512.0
Polydipsia,1005489.0,162.0
Therapeutic response unexpected,1005489.0,267.0
Therapeutic response decreased,1005489.0,2794.0
Unresponsive to stimuli,1005489.0,232.0
Candida infection,1005489.0,309.0
Loose body in joint,1005489.0,92.0
Drug level above therapeutic,1005489.0,71.0
Upper-airway cough syndrome,1005489.0,99.0
Head injury,1005489.0,92.0
Heart rate increased,1005489.0,1401.0
Skin infection,1005489.0,568.0
Abscess limb,1005489.0,78.0
Arrhythmia,1005489.0,29.0
Chest discomfort,1005489.0,204.0
Cytomegalovirus colitis,1005489.0,29.0
Hepatic cancer,1005489.0,106.0
Humerus fracture,1005489.0,85.0
Balance disorder,1005489.0,9325.0
Atrial fibrillation,1005489.0,400.0
Acute lymphocytic leukaemia recurrent,1005489.0,155.0
Toxic epidermal necrolysis,1005489.0,36.0
Hiatus hernia,1005489.0,246.0
Pneumothorax,1005489.0,106.0
Tooth infection,1005489.0,211.0
Polyhydramnios,1005489.0,267.0
Disease progression,1005489.0,162.0
SARS-CoV-2 test positive,1005489.0,393.0
Discomfort,1005489.0,2017.0
"Sleep disorder due to general medical condition, insomnia type",1005489.0,1814.0
Cold sweat,1005489.0,176.0
Hip fracture,1005489.0,351.0
Visual impairment,1005489.0,99.0
Lymphopenia,1005489.0,253.0
Acute hepatic failure,1005489.0,36.0
Intestinal haemorrhage,1005489.0,64.0
Nail disorder,1005489.0,1149.0
Knee arthroplasty,1005489.0,1814.0
Diabetes mellitus,1005489.0,414.0
Colitis,1005489.0,1016.0
Spinal operation,1005489.0,120.0
Placental insufficiency,1005489.0,92.0
Mouth ulceration,1005489.0,288.0
Lacrimation increased,1005489.0,183.0
Jaw fracture,1005489.0,85.0
Hyperkeratosis,1005489.0,148.0
Osteopenia,1005489.0,246.0
Asphyxia,1005489.0,92.0
Anaphylactic reaction,1005489.0,358.0
Parkinson's disease,1005489.0,512.0
Tooth abscess,1005489.0,50.0
Limb deformity,1005489.0,92.0
Infective pulmonary exacerbation of cystic fibrosis,1005489.0,50.0
Dust allergy,1005489.0,99.0
Chromaturia,1005489.0,92.0
Blood immunoglobulin E decreased,1005489.0,43.0
Drug reaction with eosinophilia and systemic symptoms,1005489.0,43.0
Health assessment questionnaire score increased,1005489.0,778.0
Swelling face,1005489.0,778.0
Pregnancy,1005489.0,71.0
Vasculitis necrotising,1005489.0,106.0
Limb discomfort,1005489.0,211.0
Speech disorder,1005489.0,491.0
Rhinitis allergic,1005489.0,330.0
Laryngospasm,1005489.0,162.0
Post transplant lymphoproliferative disorder,1005489.0,260.0
Dysmenorrhoea,1005489.0,155.0
Onychomadesis,1005489.0,1191.0
Hyperthyroidism,1005489.0,211.0
Neuropathy peripheral,1005489.0,197.0
Mood swings,1005489.0,106.0
Splenic rupture,1005489.0,36.0
Malignant melanoma stage I,1005489.0,148.0
Central sleep apnoea syndrome,1005489.0,85.0
Metastases to liver,1005489.0,134.0
Skin necrosis,1005489.0,1233.0
Dengue fever,1005489.0,57.0
Platelet count increased,1005489.0,92.0
Throat clearing,1005489.0,99.0
Neuralgia,1005489.0,463.0
Proteus test positive,1005489.0,1016.0
Lung hyperinflation,1005489.0,85.0
Skin disorder,1005489.0,43.0
Candida sepsis,1005489.0,50.0
Heart rate decreased,1005489.0,1037.0
Electrocardiogram ST segment elevation,1005489.0,15.0
Myelosuppression,1005489.0,113.0
Blood pressure systolic decreased,1005489.0,778.0
Multiple fractures,1005489.0,99.0
Myoclonus,1005489.0,190.0
Flank pain,1005489.0,253.0
Hepatic function abnormal,1005489.0,155.0
Nail operation,1005489.0,1149.0
Encephalitis herpes,1005489.0,36.0
Thyroid mass,1005489.0,211.0
Appendicitis,1005489.0,22.0
Albumin urine present,1005489.0,421.0
Febrile neutropenia,1005489.0,155.0
Haemoglobin increased,1005489.0,92.0
Pyelonephritis,1005489.0,211.0
Infection,1005489.0,1716.0
Abnormal behaviour,1005489.0,176.0
Small intestinal obstruction,1005489.0,8.0
Ischaemic stroke,1005489.0,1555.0
Renal impairment,1005489.0,120.0
Cataract,1005489.0,393.0
Blood pressure fluctuation,1005489.0,1030.0
Acute graft versus host disease in intestine,1005489.0,806.0
Staphylococcal infection,1005489.0,456.0
Oxygen saturation decreased,1005489.0,2143.0
Ammonia increased,1005489.0,29.0
Pleuritic pain,1005489.0,211.0
Dermatitis infected,1005489.0,1016.0
Gingival hypertrophy,1005489.0,22.0
Depressed mood,1005489.0,183.0
Central nervous system lymphoma,1005489.0,50.0
Middle insomnia,1005489.0,435.0
Blood thyroid stimulating hormone decreased,1005489.0,211.0
Intentional overdose,1005489.0,323.0
Tendonitis,1005489.0,246.0
Breast feeding,1005489.0,71.0
Ischaemic cerebral infarction,1005489.0,99.0
Haemolytic anaemia,1005489.0,113.0
Nephrocalcinosis,1005489.0,64.0
Hyperaesthesia,1005489.0,134.0
Soft tissue injury,1005489.0,778.0
Tachycardia foetal,1005489.0,36.0
Circulatory collapse,1005489.0,134.0
Poliomyelitis,1005489.0,43.0
Pneumonia bacterial,1005489.0,85.0
Mania,1005489.0,22.0
Tenderness,1005489.0,533.0
Trichosporon infection,1005489.0,43.0
Surgery,1005489.0,211.0
Pre-existing condition improved,1005489.0,85.0
Parkinsonism,1005489.0,29.0
Asthenia,1005489.0,897.0
Lipoma,1005489.0,64.0
Nervous system disorder,1005489.0,57.0
Incorrect dose administered,1005489.0,841.0
Psoriatic arthropathy,1005489.0,1716.0
Vasculitis,1005489.0,498.0
Bronchopulmonary aspergillosis,1005489.0,1016.0
Leukocytosis,1005489.0,64.0
Hair growth abnormal,1005489.0,127.0
Device malfunction,1005489.0,29.0
Urinary tract infection bacterial,1005489.0,92.0
Malignant neoplasm progression,1005489.0,134.0
Sneezing,1005489.0,253.0
Brain scan abnormal,1005489.0,1555.0
Drug level decreased,1005489.0,64.0
Cardiac arrest,1005489.0,365.0
Acne,1005489.0,246.0
Oropharyngeal pain,1005489.0,1793.0
Urinary tract infection,1005489.0,736.0
Blindness,1005489.0,78.0
Metabolic encephalopathy,1005489.0,29.0
Skull fracture,1005489.0,8.0
Mental disorder,1005489.0,589.0
Lung infiltration,1005489.0,57.0
Limb injury,1005489.0,323.0
Large intestine infection,1005489.0,1016.0
Ileal ulcer,1005489.0,64.0
Dysgraphia,1005489.0,78.0
Heart transplant rejection,1005489.0,106.0
Varicella zoster virus infection,1005489.0,50.0
Suicidal ideation,1005489.0,29.0
Yellow skin,1005489.0,22.0
Sinus congestion,1005489.0,939.0
Skin irritation,1005489.0,78.0
Gout,1005489.0,386.0
Blood pressure diastolic abnormal,1005489.0,1317.0
Abnormal weight gain,1005489.0,64.0
Inappropriate schedule of product administration,1005489.0,1366.0
Brain hypoxia,1005489.0,50.0
Osteoporotic fracture,1005489.0,92.0
Dystonia,1005489.0,225.0
Concomitant disease aggravated,1005489.0,50.0
Idiopathic intracranial hypertension,1005489.0,64.0
Mental status changes,1005489.0,43.0
Underweight,1005489.0,106.0
Acute myocardial infarction,1005489.0,267.0
Gastroenteritis viral,1005489.0,659.0
Arterial thrombosis,1005489.0,99.0
Stress,1005489.0,736.0
Pancytopenia,1005489.0,106.0
Restlessness,1005489.0,29.0
Dysphonia,1005489.0,645.0
Aspergillus test positive,1005489.0,1016.0
Urine output decreased,1005489.0,92.0
Blood creatine phosphokinase increased,1005489.0,29.0
Epistaxis,1005489.0,302.0
Seizure,1005489.0,484.0
Bacterial sepsis,1005489.0,127.0
Skin lesion,1005489.0,50.0
Feeling cold,1005489.0,43.0
Product colour issue,1005489.0,22.0
Dry eye,1005489.0,99.0
Product dose omission issue,1005489.0,491.0
Tooth fracture,1005489.0,43.0
Drug resistance,1005489.0,43.0
Oral candidiasis,1005489.0,211.0
Biliary obstruction,1005489.0,211.0
Oculogyric crisis,1005489.0,470.0
Intestinal mass,1005489.0,29.0
Drug dependence,1005489.0,197.0
Skin wound,1005489.0,43.0
Partial seizures,1005489.0,29.0
Clostridium test positive,1005489.0,274.0
Hepatic fibrosis,1005489.0,253.0
Keratoacanthoma,1005489.0,148.0
Disseminated intravascular coagulation,1005489.0,22.0
Hypoventilation,1005489.0,22.0
Acidosis,1005489.0,22.0
Pulmonary oedema,1005489.0,134.0
Clostridial infection,1005489.0,386.0
Cerebral haemorrhage,1005489.0,92.0
Metabolic acidosis,1005489.0,127.0
Clavicle fracture,1005489.0,330.0
Eyelid oedema,1005489.0,78.0
Respiratory tract infection,1005489.0,666.0
Malignant melanoma,1005489.0,148.0
Haemarthrosis,1005489.0,141.0
Epstein-Barr virus infection reactivation,1005489.0,155.0
Pulmonary toxicity,1005489.0,43.0
Cytomegalovirus infection reactivation,1005489.0,36.0
Acute graft versus host disease,1005489.0,274.0
Caesarean section,1005489.0,92.0
Sputum increased,1005489.0,330.0
Colitis ulcerative,1005489.0,99.0
Accidental overdose,1005489.0,8.0
Joint injury,1005489.0,92.0
Monoclonal B-cell lymphocytosis,1005489.0,155.0
Bone disorder,1005489.0,92.0
White blood cell count decreased,1005489.0,274.0
Photophobia,1005489.0,225.0
Blood pressure diastolic increased,1005489.0,253.0
Dysuria,1005489.0,92.0
Gynaecomastia,1005489.0,190.0
Lymphadenopathy,1005489.0,155.0
Nail growth abnormal,1005489.0,43.0
Post-anoxic myoclonus,1005489.0,29.0
Reduced facial expression,1005489.0,29.0
Vital capacity decreased,1005489.0,141.0
Brain neoplasm,1005489.0,274.0
Multiple sclerosis relapse,1005489.0,211.0
Sinusitis fungal,1005489.0,99.0
Blood iron decreased,1005489.0,120.0
Temperature intolerance,1005489.0,330.0
Muscle rigidity,1005489.0,183.0
Eyelid disorder,1005489.0,78.0
Encephalopathy,1005489.0,57.0
Skin fissures,1005489.0,78.0
Sensitivity to weather change,1005489.0,162.0
Hypoglycaemia,1005489.0,659.0
Blood uric acid increased,1005489.0,43.0
Hypertransaminasaemia,1005489.0,253.0
Rhinorrhoea,1005489.0,785.0
Gastrooesophageal reflux disease,1005489.0,99.0
Ventricular dysfunction,1005489.0,106.0
Oesophagitis,1005489.0,64.0
Immunosuppressant drug level increased,1005489.0,85.0
Thrombosis,1005489.0,225.0
Sensory loss,1005489.0,8.0
Respiratory rate increased,1005489.0,260.0
Hepatic steatosis,1005489.0,43.0
Breast cancer,1005489.0,43.0
Immunodeficiency,1005489.0,435.0
Urine odour abnormal,1005489.0,92.0
Large intestine perforation,1005489.0,8.0
Nasal dryness,1005489.0,78.0
Polycythaemia,1005489.0,64.0
Mouth injury,1005489.0,99.0
BK polyomavirus test positive,1005489.0,155.0
Infusion site discharge,1005489.0,15.0
Catheter site erythema,1005489.0,71.0
Mixed obstructive and restrictive lung disease,1005489.0,36.0
White blood cell count increased,1005489.0,113.0
Haematochezia,1005489.0,50.0
Choking,1005489.0,197.0
Foot deformity,1005489.0,253.0
Disorientation,1005489.0,155.0
Aspergillus infection,1005489.0,1016.0
Tachyphrenia,1005489.0,29.0
Aphonia,1005489.0,386.0
Ascites,1005489.0,64.0
Febrile convulsion,1005489.0,64.0
Loose tooth,1005489.0,64.0
Cholestasis,1005489.0,113.0
Hepatic cirrhosis,1005489.0,92.0
Ischaemia,1005489.0,134.0
Back disorder,1005489.0,106.0
Hemiparesis,1005489.0,15.0
Tinnitus,1005489.0,64.0
Cystitis haemorrhagic,1005489.0,155.0
Vision blurred,1005489.0,386.0
Pulseless electrical activity,1005489.0,15.0
Basilar artery thrombosis,1005489.0,120.0
Skin hypertrophy,1005489.0,92.0
Impaired driving ability,1005489.0,15.0
Urinary incontinence,1005489.0,43.0
Philadelphia chromosome positive,1005489.0,92.0
Gangrene,1005489.0,50.0
Bacterial infection,1005489.0,50.0
Crohn's disease,1005489.0,15.0
Salivary hyposecretion,1005489.0,78.0
Product availability issue,1005489.0,92.0
Intestinal obstruction,1005489.0,64.0
Labelled drug-drug interaction medication error,1005489.0,29.0
Electrocardiogram abnormal,1005489.0,29.0
Femur fracture,1005489.0,92.0
Cerebrovascular insufficiency,1005489.0,22.0
Bradycardia,1005489.0,22.0
Urinary retention,1005489.0,211.0
Platelet count abnormal,1005489.0,155.0
Embolism,1005489.0,50.0
Tachycardia,1005489.0,351.0
Breast inflammation,1005489.0,393.0
Pollakiuria,1005489.0,141.0
Breast fibroma,1005489.0,106.0
Chills,1005489.0,463.0
Lumbar vertebral fracture,1005489.0,64.0
Haemorrhage,1005489.0,680.0
Pericardial effusion,1005489.0,106.0
Hilar lymphadenopathy,1005489.0,64.0
Tubulointerstitial nephritis,1005489.0,29.0
Tongue dry,1005489.0,78.0
Hepatosplenomegaly,1005489.0,155.0
Forced expiratory flow decreased,1005489.0,197.0
Osteonecrosis,1005489.0,50.0
Phaeohyphomycosis,1005489.0,29.0
Anticonvulsant drug level below therapeutic,1005489.0,29.0
Abdominal mass,1005489.0,288.0
Cutaneous vasculitis,1005489.0,71.0
Anaphylactoid reaction,1005489.0,92.0
Rectal haemorrhage,1005489.0,57.0
Stenotrophomonas infection,1005489.0,64.0
White blood cell count abnormal,1005489.0,64.0
Gastritis bacterial,1005489.0,386.0
Toothache,1005489.0,8.0
Emotional disorder,1005489.0,169.0
Cardio-respiratory arrest,1005489.0,99.0
Retroperitoneal lymphadenopathy,1005489.0,64.0
Metabolic alkalosis,1005489.0,8.0
Gastroenteritis,1005489.0,393.0
Klebsiella infection,1005489.0,64.0
Photosensitivity reaction,1005489.0,330.0
Dysstasia,1005489.0,134.0
Affective disorder,1005489.0,22.0
Muscle contractions involuntary,1005489.0,22.0
Fungal abscess central nervous system,1005489.0,15.0
Foreign body in throat,1005489.0,22.0
Peritonitis,1005489.0,64.0
Atrioventricular block complete,1005489.0,50.0
Acute promyelocytic leukaemia,1005489.0,22.0
Graft versus host disease in skin,1005489.0,155.0
Respiratory muscle weakness,1005489.0,22.0
Chronic myeloid leukaemia,1005489.0,64.0
Personality disorder,1005489.0,106.0
Lung diffusion test decreased,1005489.0,36.0
Throat tightness,1005489.0,155.0
Generalised tonic-clonic seizure,1005489.0,8.0
Cholangiocarcinoma,1005489.0,57.0
Xanthoma,1005489.0,29.0
Colon cancer,1005489.0,148.0
Protothecosis,1005489.0,64.0
Muscle atrophy,1005489.0,22.0
Epstein-Barr virus associated lymphoproliferative disorder,1005489.0,155.0
Renal failure,1005489.0,64.0
Hyperuricaemia,1005489.0,64.0
Herpes virus infection,1005489.0,43.0
Hyperaemia,1005489.0,78.0
Exanthema subitum,1005489.0,64.0
Aphasia,1005489.0,22.0
Gestational diabetes,1005489.0,8.0
False negative investigation result,1005489.0,57.0
Venoocclusive liver disease,1005489.0,64.0
Brain herniation,1005489.0,162.0
Pulmonary alveolar haemorrhage,1005489.0,50.0
Mononucleosis syndrome,1005489.0,155.0
Cardiovascular disorder,1005489.0,22.0
Spleen palpable,1005489.0,64.0
Eye infection,1005489.0,393.0
Pallor,1005489.0,386.0
Menopause,1005489.0,393.0
Adenocarcinoma gastric,1005489.0,64.0
Overweight,1005489.0,43.0
Prostatic specific antigen increased,1005489.0,64.0
Red blood cell sedimentation rate abnormal,1005489.0,92.0
Multiple-drug resistance,1005489.0,50.0
Suicide attempt,1005489.0,8.0
Paralysis,1005489.0,43.0
Vein disorder,1005489.0,43.0
Chest pain,1005489.0,134.0
Acute respiratory distress syndrome,1005489.0,22.0
Sensory disturbance,1005489.0,22.0
Ocular icterus,1005489.0,8.0
Gastroenteritis aeromonas,1005489.0,43.0
Disturbance in attention,1005489.0,57.0
Liver palpable,1005489.0,64.0
Interstitial lung disease,1005489.0,22.0
Peripheral coldness,1005489.0,22.0
Hot flush,1005489.0,15.0
Accident,1005489.0,8.0
Immunosuppressant drug level decreased,1005489.0,64.0
Hyper IgE syndrome,1005489.0,43.0
External ear pain,1005489.0,29.0
Product label issue,1005489.0,43.0
Steatohepatitis,1005489.0,15.0
Papilloedema,1005489.0,64.0
Visual acuity reduced,1005489.0,64.0
Emphysema,1005489.0,358.0
Petechiae,1005489.0,43.0
Premature delivery,1005489.0,92.0
Onychoclasis,1005489.0,43.0
Joint laxity,1005489.0,92.0
Anger,1005489.0,141.0
Tendon disorder,1005489.0,22.0
Haemorrhoids,1005489.0,29.0
Haemoglobin decreased,1005489.0,92.0
Disability assessment scale score increased,1005489.0,393.0
Infected bite,1005489.0,386.0
Ejection fraction abnormal,1005489.0,8.0
Cytomegalovirus infection,1005489.0,43.0
Exophthalmos,1005489.0,64.0
Accidental exposure to product,1005489.0,8.0
Allergic sinusitis,1005489.0,43.0
Ear swelling,1005489.0,29.0
Pyelonephritis chronic,1005489.0,43.0
Partial seizures with secondary generalisation,1005489.0,29.0
Ecchymosis,1005489.0,22.0
Stevens-Johnson syndrome,1005489.0,36.0
Dysphagia,1005489.0,43.0
Gastrointestinal pain,1005489.0,43.0
Fibrosis,1005489.0,64.0
Fungal infection,1005489.0,50.0
Fixed eruption,1005489.0,36.0
Cystic fibrosis,1005489.0,50.0
Eye haemorrhage,1005489.0,71.0
Meningitis cryptococcal,1005489.0,57.0
Cerebral artery embolism,1005489.0,15.0
Enterococcal infection,1005489.0,64.0
Product prescribing issue,1005489.0,29.0
Intracranial hypotension,1005489.0,8.0
Ligament sprain,1005489.0,29.0
Scar,1005489.0,15.0
Drug screen positive,1005489.0,22.0
Autonomic nervous system imbalance,1005489.0,22.0
Systemic candida,1005489.0,29.0
Metabolic disorder,1005489.0,22.0
Homicide,1005489.0,15.0
Allergic reaction to excipient,1005489.0,43.0
Varicose vein,1005489.0,43.0
Legionella infection,1005489.0,43.0
Tardive dyskinesia,1005489.0,71.0
Shock,1005489.0,29.0
Enterocolitis,1005489.0,8.0
Tendon pain,1005489.0,22.0
Drooling,1005489.0,22.0
Pulmonary mass,1005489.0,43.0
Limb mass,1005489.0,43.0
Respiratory alkalosis,1005489.0,43.0
FEV1/FVC ratio decreased,1005489.0,50.0
Eye disorder,1005489.0,36.0
Neuroleptic malignant syndrome,1005489.0,22.0
Brugada syndrome,1005489.0,15.0
Tracheal disorder,1005489.0,22.0
Scedosporium infection,1005489.0,15.0
Myocarditis,1005489.0,15.0
Decreased activity,1005489.0,512.0
COVID-19,1005489.0,162.0
Protein urine present,1005489.0,43.0
Viral infection,1005489.0,162.0
Intentional self-injury,1005489.0,484.0
Nephritis,1005489.0,43.0
Product administered to patient of inappropriate age,1005489.0,8.0
Traumatic haemorrhage,1005489.0,71.0
Haematological infection,1005489.0,484.0
Polyp,1005489.0,162.0
Forced vital capacity decreased,1005489.0,246.0
Substance abuse,1005489.0,15.0
Renal pain,1005489.0,85.0
Ventricular tachycardia,1005489.0,8.0
Incorrect dose administered by device,1005489.0,43.0
Intentional product misuse,1005489.0,36.0
Abdominal pain lower,1005489.0,43.0
Cardiomyopathy,1005489.0,8.0
Dysgeusia,1005489.0,22.0
Wrong technique in product usage process,1005489.0,603.0
Infarction,1005489.0,15.0
Coagulopathy,1005489.0,29.0
Breast discharge,1005489.0,15.0
Hair colour changes,1005489.0,22.0
Lethargy,1005489.0,8.0
Groin pain,1005489.0,43.0
Needle issue,1005489.0,43.0
Drug level increased,1005489.0,8.0
Increased appetite,1005489.0,197.0
Normal newborn,1005489.0,8.0
Electrocardiogram QRS complex prolonged,1005489.0,15.0
Fear of injection,1005489.0,43.0
"Hallucination, auditory",1005489.0,8.0
Blood creatinine increased,1005489.0,29.0
Haematoma,1005489.0,29.0
Bronchiectasis,1005489.0,36.0
Aplastic anaemia,1005489.0,15.0
Breakthrough pain,1005489.0,22.0
